There were no differences between the two groups regarding pulse pressure, dyslipidemia, duration of kidney disease, or laboratory results (platelet count, Hb, total cholesterol, HDL cholesterol, and triglyceride). The gene discussed is GSTM1; the disease is metabolic syndrome.